Welcome VHypotenuse as a corporate member
Date: July 1, 2025
The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as a new corporate member.
Founded in 2021, VHypotenuse was born from a deep-rooted passion for science and technology, driven by a strong desire to make a meaningful impact on the world. Originally established as an IT and Data Management company, VHypotenuse has since expanded into the field of Clinical Research, conducting clinical trials across a range of therapeutic areas. At VHypotenuse, they are committed to delivering innovative and reliable solutions to our clients.
VHypotenuse joined the ACDM as part of its ongoing commitment to upholding the highest standards in clinical research and data integrity. The association offers a valuable platform for collaboration, learning, and contributing to best practices, supporting VHypotenuse’s mission to enhance quality, efficiency, and compliance in clinical trials while advancing patient safety and scientific rigour.
Members gain many benefits from membership, including:
- Access to training courses at a discounted rate
- Assign full ACDM membership to all individuals within your organisation
- Place an organisation profile, description and logo on the ACDM website
- Advertise jobs for your positions within your organisation
- Reduced price attendance at conferences and symposia
- Free attendance at Hot Topics
Find out more about becoming a corporate member here.
Explore More News
AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?
At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .
Read More
Newsletter Committee: Meet Neha
The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee.
Neha shares . . .
Read More
Newsletter Committee: Meet Sylvain
The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .
Read More
Welcome VHypotenuse as a corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .
Read More
Newsletter Committee: Meet Marta
The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .
Read More
AI model trained on de-identified data from 57 million people
Researchers at UCL have trained an AI model using de-identified data from 57 million . . .
Read More
ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released
The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .
Read More
ICH E6(R3) Guideline reaches Step 4 of the ICH Process
ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025.
The guideline . . .
Read More
U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties
The U.S. Food and Drug Administration has issued its first guidance on the use of . . .
Read More
ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025
As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .
Read More
Audit Trail Review DMEG Update – New Guide
The Audit Trail Review (ATR) DMEG has been hard at work putting the finishing touches on a . . .
Read More
Risk Based Quality Management DMEG Update – Recent Discussions
This year our focus has switched away from generalised RBQM to applying risk-based . . .
Read More
